Monetary values: Common Case Study

The text on this page is taken from an equivalent page of the IEHIAS-project.

Health End-Point	Low	Central	High	Unit (2010) per case
Sleep disturbance	480	1,240	1,570	Euro/year
Hypertension	880	950	1,110	Euro/year
Acute myocardial infarction	4,675	86,200	436,200	Euro
Increased mortality risk (infants)	1,120,000	4,485,731	11,200,000	Euro
New cases of chronic bronchitis	43,000	66,000	100,000	Euro
Severe COPD	70,000	120,000	260,000	Euro
Increased mortality risk - Value Of Life Years	89,715	89,715	89,715	Euro
Increased mortality risk - VSLacute	1,121,433	1,121,433	5,607,164	Euro
Increased mortality risk - VPFacute	1,120,000	1,650,000	5,600,000	Euro
Life expectancy reduction - Value of Life Years chronic	37,500	59,810	213,820	Euro
Respiratory hospital admissions	2,990	2,990	8,074	Euro
Cardiac hospital admissions	2,990	2,990	8,074	Euro
Work loss days (WLD)	441	441	441	Euro
Restricted activity days (RADs)	194	194	194	Euro
Minor restricted activity days (MRAD)	57	57	57	Euro
Lower respiratory symptoms	57	57	57	Euro
LRS excluding cough	57	57	57	Euro
Cough days	57	57	57	Euro
Medication use / bronchodilator use	74	80	96	Euro
Lung cancer	69,080	719,212	4,187,879	Euro
Leukaemia	2,045,493	3,974,358	7,114,370	Euro
Neuro-development disorders	4,486	14,952	32,895	Euro
Skin cancer	10,953	13,906	26,765	Euro
Osteoporosis	2,990	5,682	8,074	Euro
Renal dysfunction	22,788	30,406	40,977	Euro
Anaemia	748	748	748	Euro

See also

• Monetasiation methods
• Deriving and applying monetary values